|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
ATE410186T1
(de)
|
2003-06-26 |
2008-10-15 |
Control Delivery Sys Inc |
In-situ gelierendes arzneimittelabgabesystem
|
|
KR101242486B1
(ko)
|
2004-01-12 |
2013-03-13 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
장기 전달을 위한 제형 및 그의 이용 방법
|
|
EP1576952A1
(en)
|
2004-03-18 |
2005-09-21 |
OctoPlus Technologies B.V. |
Hydrogel microspheres with improved release profile
|
|
NL1026261C2
(nl)
|
2004-05-25 |
2005-11-28 |
Nanomi B V |
Sproei inrichting met een nozzleplaat voorzien van structuren ter bevordering van self-breakup, een nozzleplaat, alsmede werkwijzen ter vervaardiging en toepassing van een dergelijke nozzleplaat.
|
|
PL1768650T3
(pl)
|
2004-06-04 |
2009-01-30 |
Camurus Ab |
Ciekłe formulacje depot
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
WO2007139744A2
(en)
|
2006-05-23 |
2007-12-06 |
Titan Pharmaceuticals, Inc. |
Implantable polymeric device for sustained release of buprenorphine with minimal initial burst
|
|
EP2054073B1
(en)
|
2006-07-11 |
2014-11-26 |
Foresee Pharmaceuticals, Inc. |
Pharmaceutical compositions for sustained release delivery of peptides
|
|
FI20070174A0
(fi)
|
2007-02-28 |
2007-02-28 |
Delsitech Oy |
Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
|
|
KR100805208B1
(ko)
|
2007-03-27 |
2008-02-21 |
주식회사 펩트론 |
엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법
|
|
WO2008130158A1
(en)
|
2007-04-19 |
2008-10-30 |
Dong-A Pharmaceutical. Co., Ltd |
A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof
|
|
EP2152315B1
(en)
|
2007-05-25 |
2016-01-06 |
Indivior UK Limited |
Sustained delivery formulations of risperidone compounds
|
|
ES2324009B1
(es)
|
2007-11-23 |
2010-05-21 |
Gp Pharm S.A. |
Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
|
|
US20090181068A1
(en)
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
|
US8877225B2
(en)
|
2008-06-03 |
2014-11-04 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
|
KR101626632B1
(ko)
|
2008-08-12 |
2016-06-01 |
노파르티스 아게 |
제약 조성물
|
|
WO2010040188A1
(en)
|
2008-10-10 |
2010-04-15 |
The Bionic Ear Institute |
Biodegradable polymer - bioactive moiety conjugates
|
|
EA201100765A1
(ru)
|
2008-12-15 |
2012-04-30 |
Бинд Биосаиэнсис |
Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
|
|
CA2792484C
(en)
|
2009-03-12 |
2017-10-31 |
Delpor, Inc. |
Implantable device for long-term delivery of drugs
|
|
AU2016228315B2
(en)
*
|
2009-09-17 |
2018-01-04 |
Bespoke Bioscience, Llc |
Role of n-2 hydroxy-ethyl-piperazine-n'-2-ethane sulfonic acid (hepes) in pain control and reversal of demyelinization injury
|
|
US8758780B2
(en)
|
2009-10-06 |
2014-06-24 |
Ascendis Pharma As |
Subcutaneous paliperidone composition
|
|
WO2011080733A1
(en)
|
2010-01-04 |
2011-07-07 |
Mapi Pharma Limited |
Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
|
|
EP2343046A1
(en)
|
2010-01-08 |
2011-07-13 |
Nirvana's Tree House B.V. |
Functionalised triblock copolymers and compositions containing such polymers
|
|
SI2394663T1
(sl)
|
2010-05-31 |
2022-02-28 |
Laboratorios Farmaceuticos Rovi, S.A. |
Sestave za injicirane biološko razgradljive vsadke in situ
|
|
UA111162C2
(uk)
|
2010-08-04 |
2016-04-11 |
Флекшен Терап'Ютікс, Інк. |
Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
|
|
FR2968994B1
(fr)
|
2010-12-17 |
2012-12-28 |
Flamel Tech Sa |
Procede de preparation de nanoparticules
|
|
MY165655A
(en)
|
2010-12-29 |
2018-04-18 |
Medincell |
Biodegradable drug delivery compositions
|
|
LT2717914T
(lt)
|
2011-06-10 |
2020-03-25 |
Ramscor, Inc. |
Sulėtinto atpalaidavimo kompozicijos, skirtos baltymų pateikimui į akį, ir jų paruošimo būdai
|
|
WO2013063125A1
(en)
|
2011-10-24 |
2013-05-02 |
Endo Pharmaceuticals Solutions Inc. |
Implantable drug delivery compositions and methods of treatment thereof
|
|
JP6282231B2
(ja)
|
2012-01-23 |
2018-02-21 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子
|
|
US20140323517A1
(en)
|
2013-04-30 |
2014-10-30 |
Heron Therapeutics, Inc. |
Compositions and methods for injection of a biodegradable polymer-based delivery system
|
|
PT3010962T
(pt)
|
2013-06-20 |
2017-09-05 |
Pharmathen Sa |
Preparação de micropartículas polilactida-poliglicolida com um perfil de libertação sigmoide
|
|
FR3034019B1
(fr)
*
|
2015-03-26 |
2017-03-17 |
Servier Lab |
Nouvelle association entre le 8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8-dihydro-3h-[1,3]oxazino[6,5-g] [1,2,3]benzotriazine-4,9-dione et un antidepresseur et les compositions pharmaceutiques qui la contiennent
|
|
KR101900482B1
(ko)
*
|
2017-01-17 |
2018-09-19 |
한국화학연구원 |
미립구형 서방출 주사제 및 그의 제조방법
|
|
AU2018349284B2
(en)
*
|
2017-10-09 |
2023-11-16 |
428 Pharma BV. |
New salt and solid state forms of escitalopram
|
|
KR102089737B1
(ko)
*
|
2017-11-01 |
2020-03-16 |
한국화학연구원 |
에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
|